Collegium Pharmaceutical, Inc.
Records under this name other than the patents Collegium Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Collegium Pharmaceutical, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,512,751 | Pharmaceutical Compositions For Sleep Disorders Lapsed on the fee record Ended Aug 20, 2025 · High confidence | Lapsed on the fee record | Ended Aug 20, 2025 | High confidence |
| US 8,758,813 | Abuse-Deterrent Drug Formulations Term ended Term ended Jun 10, 2025 · High confidence | Term ended | Term ended Jun 10, 2025 | High confidence |
| US 7,399,488 | Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs Term ended Term ended Mar 24, 2025 · High confidence | Term ended | Term ended Mar 24, 2025 | High confidence |
| US 8,449,909 | Abuse-Deterrent Drug Formulations Term ended Term ended Mar 24, 2025 · High confidence | Term ended | Term ended Mar 24, 2025 | High confidence |
| US 8,557,291 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Mar 21, 2025 · High confidence | Term ended | Term ended Mar 21, 2025 | High confidence |
| US 7,038,085 | Stereoisomers of P-Hydroxy-Milnacipran, and Methods of Use Thereof Term ended Term ended Oct 22, 2023 · High confidence | Term ended | Term ended Oct 22, 2023 | High confidence |
| US 8,840,928 | Tamper-Resistant Pharmaceutical Compositions of Opiods and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Term ended | Term ended Jul 7, 2023 | High confidence |
| US 9,044,398 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Term ended | Term ended Jul 7, 2023 | High confidence |
| US 9,248,195 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Term ended | Term ended Jul 7, 2023 | High confidence |
| US 9,592,200 | Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs Term ended Term ended Jul 7, 2023 · High confidence | Term ended | Term ended Jul 7, 2023 | High confidence |